Treatment of stiff person syndrome with rituximabBAKER, M. R; DAS, M; ISAACS, J et al.Journal of neurology, neurosurgery and psychiatry. 2005, Vol 76, Num 7, pp 999-1001, issn 0022-3050, 3 p.Article

Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIgRÜEGG, Stephan J; FUHR, Peter; STECK, Andreas J et al.Neurology. 2004, Vol 63, Num 11, pp 2178-2179, issn 0028-3878, 2 p.Article

Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screeningGASPARETTO, Maura; GENTRY, Tracy; SMITH, Clay et al.Journal of immunological methods. 2004, Vol 292, Num 1-2, pp 59-71, issn 0022-1759, 13 p.Article

Rituximab for tumefactive inflammatory demyelination: A case reportXUEWEN FAN; MAHTA, Ali; DE JAGER, Philip L et al.Clinical neurology and neurosurgery (Dutch-Flemish ed.). 2012, Vol 114, Num 10, pp 1326-1328, issn 0303-8467, 3 p.Article

Successful treatment with rituximab of one patient with CANOMAD neuropathyDELMONT, Emilien; JEANDEL, P. Y; HUBERT, A. M et al.Journal of neurology. 2010, Vol 257, Num 4, pp 655-657, issn 0340-5354, 3 p.Article

An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromesSHAMS'ILI, Setareh; DE BEUKELAAR, Janet; GRATAMA, Jan Willem et al.Journal of neurology. 2006, Vol 253, Num 1, pp 16-20, issn 0340-5354, 5 p.Article

Does rituximab aggravate pre-existing hypogammaglobulinaemia?DIWAKAR, Lavanya; GORRIE, Sheryl; RICHTER, Alex et al.Journal of clinical pathology. 2010, Vol 63, Num 3, pp 275-277, issn 0021-9746, 3 p.Article

Innovative Uses of Rituximab in DermatologyCARR, David R; HEFFERNAN, Michael P.Dermatologic clinics. 2010, Vol 28, Num 3, issn 0733-8635, 547-557, viii-ix [13 p.]Article

Update on rituximabEISENBERG, R.Annals of the rheumatic diseases. 2005, Vol 64, pp iv55-iv57, issn 0003-4967, SUP4Conference Paper

Chronic neuropathy with igm antiganglioside antibodies: Lack of long term response to rituximabROJAS-GARCIA, R; GALLARDO, E; DE ANDRES, I et al.Neurology. 2003, Vol 61, Num 12, pp 1814-1816, issn 0028-3878, 3 p.Article

Quantitative analysis of protein co-localization on B cells opsonized with rituximab and complement using the ImageStream multispectral imaging flow cytometerBEUM, Paul V; LINDORFER, Margaret A; HALL, Brian E et al.Journal of immunological methods. 2006, Vol 317, Num 1-2, pp 90-99, issn 0022-1759, 10 p.Article

The therapeutic potential of anti-CD20 What do B-cells do?EISENBERG, Robert; LOONEY, R. John.Clinical immunology (Orlando, Fla. Print). 2005, Vol 117, Num 3, pp 207-213, issn 1521-6616, 7 p.Article

Rituximab in Severe Seronegative Juvenile Myasthenia Gravis: Review of the LiteratureKOUL, Roshan; FUTAISI, Amna Al; ABDWANI, Reem et al.Pediatric neurology. 2012, Vol 47, Num 3, pp 209-212, issn 0887-8994, 4 p.Article

Long-lasting treatment effect of rituximab in MuSK myastheniaDIAZ-MANERA, J; MARTINEZ-HERNANDEZ, E; JUAREZ, C et al.Neurology. 2012, Vol 78, Num 3, pp 189-193, issn 0028-3878, 5 p.Article

Rituximab : Applications in dermatologyFATOURECHI, Mitra M; EL-AZHARY, Rokea A; GIBSON, Lawrence E et al.International journal of dermatology. 2006, Vol 45, Num 10, pp 1143-1155, issn 0011-9059, 13 p.Article

Use of rituximab to decrease panel-reactive antibodiesBALFOUR, Ian C; FIORE, Andrew; GRAFF, Ralph J et al.The Journal of heart and lung transplantation. 2005, Vol 24, Num 5, pp 628-630, issn 1053-2498, 3 p.Article

Pharmacokinetics of rituximab and its clinical use : Thought for the best use? : Antibodies in cancer treatment - Part ICARTRON, Guillaume; BLASCO, Hélène; PAINTAUD, Gilles et al.Critical reviews in oncology/hematology. 2007, Vol 62, Num 1, pp 43-52, issn 1040-8428, 10 p.Article

The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disordersFRANCHINI, Massimo; VENERI, Dino; LIPPI, Giuseppe et al.Thrombosis and haemostasis. 2006, Vol 96, Num 2, pp 119-125, issn 0340-6245, 7 p.Article

Placebo-controlled trial of rituximab in IgM anti-myelin―associated glycoprotein neuropathyLEGER, Jean-Marc; VIALA, Karine; MARIN, Benoit et al.Neurology. 2013, Vol 80, Num 24, pp 2217-2225, issn 0028-3878, 9 p.Article

Rituximab for Remission Induction and Maintenance in Refractory Granulomatosis With Polyangiitis (Wegener's): Ten-Year Experience at a Single CenterCARTIN-CEBA, Rodrigo; GOLBIN, Jason M; KEOGH, Karina A et al.Arthritis and rheumatism. 2012, Vol 64, Num 11, pp 3770-3778, issn 0004-3591, 9 p.Article

Placebo-Controlled Trial of Rituximab in IgM Anti-Myelin-Associated Glycoprotein Antibody Demyelinating NeuropathyDALAKAS, Marinos C; RAKOCEVIC, Goran; SALAJEGHEH, Mohammad et al.Annals of neurology. 2009, Vol 65, Num 3, pp 286-293, issn 0364-5134, 8 p.Article

Interindividual Variability of Response to Rituximab: From Biological Origins to Individualized TherapiesCARTRON, Guillaume; ULRICH TRAPPE, Ralf; SOLAL-CELIGNY, Philippe et al.Clinical cancer research (Print). 2011, Vol 17, Num 1, pp 19-30, issn 1078-0432, 12 p.Article

Use and monitoring of low dose rituximab in myasthenia gravisBLUM, Stefan; GILLIS, David; PILLANS, Peter et al.Journal of neurology, neurosurgery and psychiatry. 2011, Vol 82, Num 6, pp 661-665, issn 0022-3050, 5 p.Article

Rituximab-induced acute severe thrombocytopeniaPARAJULI, Ritesh; HIRE, Ervin; SHAH, Binay K et al.British journal of haematology. 2010, Vol 149, Num 6, issn 0007-1048, p. 804Article

Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker resultsKAVANAUGH, A; ROSENGREN, S; LEE, S. J et al.Annals of the rheumatic diseases. 2008, Vol 67, Num 3, pp 402-408, issn 0003-4967, 7 p.Article